Number of Shares
694,403.00
Current Holdings Value*
$171.34 Mil
% of Portfolio
4.05%
Total Estimate Gain
$90.02 Mil
% of Total Estimate Gain
30.17%

Select Biotechnology Portfolio's Alnylam Pharmaceuticals Inc Holding Summary

As of 2025-02-28, Select Biotechnology Portfolio held 694,403.00 shares of Alnylam Pharmaceuticals Inc(ALNY), totaling $171.34 Mil. This investment constitutes 4.05% of their stock portfolio, and Select Biotechnology Portfolio now holds 0.53% of the outstanding Alnylam Pharmaceuticals Inc(ALNY) stock.

The initial trade took place in 2021Q4. And since then Select Biotechnology Portfolio has made 3 purchases of ALNY, at an average price of $190.72, for a total of 1.56 Mil shares. In addition, there have been 10 sales at an average price of $187.26 for 870,218.00 shares. Based on historical transaction data and ALNY's current price of $324.69, Select Biotechnology Portfolio's estimated gain on his ALNY holdings is $90.02 Mil, reflecting a 30.17% gain to date.

Select Biotechnology Portfolio ALNY ($324.69) Holding Chart

Select Biotechnology Portfolio ALNY ($324.69) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1